Citation Impact
Citing Papers
Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk
2007
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis
2002
Adhesion molecules in rheumatoid arthritis
1998
Inflammation and cancer
2002 StandoutNature
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Psoriasis
2009 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
The role of IL-12 in the induction of organ-specific autoimmune diseases
1995
Rheumatoid arthritis
2016 Standout
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Th1/Th2 Cells
1999
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Autoimmune Diseases
2001
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences
2005
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
2004
Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy
2002
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
2003 StandoutNature
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Animal models of inflammatory spinal and sacroiliac joint diseases
2003
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
2009
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
2007
CD14 is required for MyD88-independent LPS signaling
2005 StandoutNobel
Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease
1995
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept
2005
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
2000
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data
2005
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Conventional treatments for ankylosing spondylitis
2002
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
How interferon-γ keeps autoimmune diseases in check
2008
The interface between innate and adaptive immunity
2004 StandoutNobel
Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases
2001
Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: A register study
2001
Human cartilage glycoprotein‐39 as a candidate autoantigen in rheumatoid arthritis
1997
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Graves' Ophthalmopathy
2010 Standout
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
2004
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
1997 StandoutNobel
Ankylosing spondylitis
2007 Standout
How important are T cells in chronic rheumatoid synovitis?: II. T cell‐independent mechanisms from beginning to end
2002
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin‐10 and interleukin‐4
1996
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept
2005
Inhibition of Interferon Gamma Production by Peripheral Blood Mononuclear Leukocytes of Patients with Sarcoidosis
1992
Osteoclast differentiation and activation
2003 StandoutNature
A longitudinal study on an autoimmune murine model of ankylosing spondylitis
2005
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis
2003
HLA–B27–restricted CD8+ T cell response to cartilage‐derived self peptides in ankylosing spondylitis
2005
Idiopathic Pulmonary Fibrosis
2001 Standout
Sarcoidosis
1997 Standout
Rheumatoid arthritis
2010 Standout
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
1997
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
2010
Classification of inflammatory arthritis by enthesitis
1998
Psoriasis
2003
The Inflammasomes
2010 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
2008
Cytokine gene polymorphisms relevant for the spondyloarthropathies
2001
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab
2005
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006 StandoutNobel
B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse
2004 StandoutNobel
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
2006 StandoutNature
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
One‐year open‐label trial of thalidomide in ankylosing spondylitis
2002
Development of anti-TNF therapy for rheumatoid arthritis
2002
Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?
2003
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
2002
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
2004
Cancer-related inflammation
2008 StandoutNature
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
2005
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial
2005
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
1995
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Pathogen Recognition and Innate Immunity
2006 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
2008
Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy
1999
Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis
2002
Autoimmunity and Anti-TNF-α Agents
2005
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
1998
Selective Expression and Functions of Interleukin 18 Receptor on T Helper (Th) Type 1 but not Th2 Cells
1998
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease
2005 StandoutNobel
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
1998
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution
2002
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
2005
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
1997 Standout
TLRs and innate immunity
2008 StandoutNobel
Th1/Th2 cells
2007
Regulation of Interleukin (IL)-12 Receptor β2 Subunit Expression by Endogenous IL-12: A Critical Step in the Differentiation of Pathogenic Autoreactive T Cells
1999
Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4.
1995
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
2003
Interleukin‐17: the missing link between T‐cell accumulation and effector cell actions in rheumatoid arthritis?
2004
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Works of J. Sieper being referenced
Recent advances in the pathogenesis of reactive arthritis
1996
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
2007
Pathogenesis of spondylarthropathies
1995
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
Inzeptionskohorte für Spondylarthropathien
2000
Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma
1988
RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES
1998
Modulating the Th1/Th2 balance in inflammatory arthritis
1998
Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging.
1996
Divergent T-cell cytokine patterns in inflammatory arthritis.
1994